Vaccines
US health authorities, including the Centers for Disease Control and Prevention (CDC), recommended Pfizer's and Moderna's two-course vaccination program over Johnson & Johnson's (J&J) single vaccine due to similar health concerns. Despite this, the FDA determined that the benefits of the J&
Vaccines
Amnesty International has called on institutional investors to use their influence to ensure that supplies of urgently needed life-saving vaccines reach low- and lower-middle-income countries. The organization has criticized pharmaceutical companies for monopolizing technology, blocking and lobbying against the sharing of intellectual property, charging high prices for vaccines, and prioritizing
Vaccines
Valneva SE and Pfizer Inc announced positive Phase 2 paediatric results for their Lyme disease vaccine candidate, VLA15, on April 26, 2022. The new data plan to include paediatric participants in their upcoming Phase 3 trial, evaluating VLA15 in adults and children aged 5 years and above. The Phase 2
Vaccines
The ongoing COVID-19 pandemic has led to the development and use of various vaccines, with mRNA-1273 and BNT162b2 being two of the most prominent ones. A recent study aimed to determine the clinical and economic impact of differences in effectiveness between these two vaccines as booster shots in US adults
Vaccines
The Department of Health (DOH) has announced that the Food and Drug Administration (FDA) has authorized the use of Janssen Covid-19 vaccine as a booster shot among fully vaccinated adults in the Philippines. This decision comes after the Philippine FDA approved the emergency use authorization for the vaccine. The Janssen
Vaccines
Research conducted at the JSS Academy of Higher Education and Research in India has found that the COVID-19 pandemic has caused a significant increase in hesitancy among mothers for routine immunization of their children. The study, published in Clinical Epidemiology and Global Health, aimed to estimate the prevalence of hesitancy
Vaccines
A study conducted at the Lithuanian University of Health Sciences aimed to investigate the safety and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine among healthcare workers 21 days after the first dose. Researchers analyzed data from 4,181 vaccine recipients and found that the first dose was associated with a 53.
Vaccines
A subgroup analysis of a global phase 3 randomized clinical trial has found that the BNT162b2 mRNA COVID-19 vaccine was safe and efficacious against infection, hospitalization, and death in individuals with a history of cancer. The study, conducted by researchers at Pfizer, included 46,429 participants aged 12 years and
Vaccines
As of March 24, nearly 256 million people in the United States have received at least one dose of a COVID-19 vaccine, representing 76.8% of the total population. However, with the surge of the Omicron variant BA.2, concerns about the effectiveness of current vaccines and the need for
Vaccines
Researchers from the University of Michigan have investigated the effectiveness of three COVID-19 vaccines in individuals on immunosuppressants for various conditions. Their study, published in the Annals of the Rheumatic Diseases, highlights the importance of booster doses for individuals on immunosuppressants. Key Takeaways: * The study analyzed data from 97,688
Vaccines
The Food and Drug Administration has authorized an additional dose of the Pfizer or Moderna vaccine for Americans 50 and older, as well as certain younger people with severely weakened immune systems. This decision expands the eligibility for a booster shot to millions more Americans, especially those with chronic illnesses
Vaccines
A series of five cases of Herpes Zoster occurring after vaccination with a nucleoside-modified messenger RNA (mRNA) COVID-19 vaccine has been reported by researchers at the Hospital Center University of Lille. The cases do not establish causality between COVID-19 vaccination and Herpes Zoster, but local vaccine-induced immunomodulation may be involved.
